[go: up one dir, main page]

AU688259B2 - Hepatitis C virus peptides - Google Patents

Hepatitis C virus peptides

Info

Publication number
AU688259B2
AU688259B2 AU35725/93A AU3572593A AU688259B2 AU 688259 B2 AU688259 B2 AU 688259B2 AU 35725/93 A AU35725/93 A AU 35725/93A AU 3572593 A AU3572593 A AU 3572593A AU 688259 B2 AU688259 B2 AU 688259B2
Authority
AU
Australia
Prior art keywords
hepatitis
virus peptides
peptides
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU35725/93A
Other versions
AU3572593A (en
Inventor
Ian Pike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU3572593A publication Critical patent/AU3572593A/en
Application granted granted Critical
Publication of AU688259B2 publication Critical patent/AU688259B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU35725/93A 1992-02-28 1993-02-26 Hepatitis C virus peptides Ceased AU688259B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9204274 1992-02-28
GB929204274A GB9204274D0 (en) 1992-02-28 1992-02-28 Novel peptides
PCT/GB1993/000410 WO1993017111A1 (en) 1992-02-28 1993-02-26 Hepatitis c virus peptides

Publications (2)

Publication Number Publication Date
AU3572593A AU3572593A (en) 1993-09-13
AU688259B2 true AU688259B2 (en) 1998-03-12

Family

ID=10711198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35725/93A Ceased AU688259B2 (en) 1992-02-28 1993-02-26 Hepatitis C virus peptides

Country Status (10)

Country Link
EP (1) EP0628079A1 (en)
JP (1) JPH07504562A (en)
AU (1) AU688259B2 (en)
CA (1) CA2131028A1 (en)
CZ (1) CZ285834B6 (en)
FI (1) FI943929A0 (en)
GB (1) GB9204274D0 (en)
SK (1) SK103594A3 (en)
WO (1) WO1993017111A1 (en)
ZA (1) ZA931299B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2711670B1 (en) * 1993-10-22 1996-01-12 Pasteur Institut Nucleotide vector, composition containing it and vaccine for immunization against hepatitis.
EP0829488A4 (en) * 1995-04-28 1999-04-07 Srl Inc ANTIGENIC PEPTIDE COMPOUND AND IMMUNOLOGICAL ASSAY METHOD
FR2775690B1 (en) * 1998-03-09 2001-12-14 Bio Merieux MONOCLONAL ANTIBODIES AND USES TO DETECT CORE PROTEIN ANTIGENS OF HCV
CA2316130A1 (en) * 1999-08-19 2001-02-19 Masanori Fukui Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014436A1 (en) * 1989-05-18 1990-11-29 Chiron Corporation Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
WO1993000365A2 (en) * 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940000755B1 (en) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Synthetic peptides specific for the detection of antibodies to hcv

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014436A1 (en) * 1989-05-18 1990-11-29 Chiron Corporation Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
WO1993000365A2 (en) * 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides

Also Published As

Publication number Publication date
CZ285834B6 (en) 1999-11-17
SK103594A3 (en) 1995-06-07
EP0628079A1 (en) 1994-12-14
WO1993017111A1 (en) 1993-09-02
FI943929L (en) 1994-08-26
CA2131028A1 (en) 1993-09-02
JPH07504562A (en) 1995-05-25
CZ206894A3 (en) 1995-03-15
AU3572593A (en) 1993-09-13
GB9204274D0 (en) 1992-04-08
ZA931299B (en) 1993-10-13
FI943929A7 (en) 1994-08-26
FI943929A0 (en) 1994-08-26

Similar Documents

Publication Publication Date Title
AU2064297A (en) Hepatitis c virus ribozymes
AU688344B2 (en) Hepatitis C virus proliferation inhibitor
AU3434393A (en) Targeted virus
HK1004896B (en) Peptides
AU6304996A (en) Vaccines against hepatitis c
AU2550995A (en) Hepatitis c virus asialoglycoproteins
AU4878096A (en) Hepatitis b vaccine
EP1256352A3 (en) Immunomodulatory peptides
AU2371692A (en) Recombinant hepatitis a virus vaccine
AU3119895A (en) Recombinant virus vectors
AU4450093A (en) Hepatitis A virus vaccine
AU4841593A (en) Improved handtruck
AU2683792A (en) Peptide based hepatitis c virus immunoassays
AU3961793A (en) Virus resistant plants
AU6299594A (en) Recombinant fowlpox virus s-fpv-043 and uses thereof
AU5679394A (en) Hepatitis b virus vaccines
EP0747482A3 (en) Hepatitis GB virus recombinant proteins and uses thereof
AU3509693A (en) A recombinant hepatitis C virus polypeptide
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
AU1522792A (en) Multiple hepatitis b virus surface proteins which form particles
AU6715094A (en) Recombinant vaccine
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
AU688259B2 (en) Hepatitis C virus peptides
AU7679491A (en) Hepatitis c virus protease inhibitors
AU4399197A (en) Hepatitis c virus epitope

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired